GlassScriptPhysician profile
Douglas M Long
NPI 1255368528
$560.77
in general payments reported to CMS, 2019-2025
10 companies · $82.64 in 2025
The $82.64 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $155 · 2023: $106 · 2024: $217 · 2025: $82.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $267.62 | 2022-2025 | Clareon, Hydrus Microstent |
| Rxsight INC | $55.37 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Abbvie INC. | $49.16 | 2022-2025 | |
| Rayner Intraocular Lenses Limited | $44.15 | 2022-2023 | Omidria, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $40.21 | 2024-2025 | Vyzulta |
| Genentech USA, INC. | $26.96 | 2023 | Vabysmo |
| Glaukos Corporation | $21.52 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $21.17 | 2023 | Cequa |
| Regeneron Healthcare Solutions, INC. | $18.33 | 2023 | Eylea |
| Thea Pharma INC. | $16.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.